LIQUIDIA TECHNOLOGIES INC

LQDA NASDAQ
5.66
+0.07
+1.25%
已收盘, 16:00 08/22 EDT
开盘
5.68
昨收
5.59
最高
6.28
最低
5.38
成交量
12.62万
成交均量(3M)
7.60万
52周最高
38.46
52周最低
4.940
换手率
0.83%
市值
8,554.98万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供LIQUIDIA TECHNOLOGIES INC LQDA股票价格,LIQUIDIA TECHNOLOGIES INC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Liquidia Technologies, Inc. is a clinical biopharmaceutical company, which is focused on the developing and commercialization of human therapeutics using its PRINT technology. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The Company is engaged in developing product candidates from its pipeline, LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. LIQ861 is an inhaled dry powder formulation of treprostinil designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies. LIQ865, has completed a Phase Ib clinical trial, is designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic and to treat local post-operative pain.
展开 >

最近浏览

名称
价格
涨跌幅